| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 03/23/2005 | CN1597953A Intracellular domain of the her-2/neu protein for prevention or treatment of maligancies |
| 03/23/2005 | CN1597952A Nerve growth factor cDNA, clone and expresion of Chinese cobra |
| 03/23/2005 | CN1597951A Artificial synthesised scorpion chloride ion neurotoxin gene-rBmK CTa |
| 03/23/2005 | CN1597950A Icam-4 materials and methods |
| 03/23/2005 | CN1597945A Extracting norfibroase from snake venom and preparation process for liquid drugs injection of norfibroase |
| 03/23/2005 | CN1597941A 10-23 desoxyribonuclease of bacillus resisting tubercle branch |
| 03/23/2005 | CN1597939A Multifunctional anticancer recombined adenovirus |
| 03/23/2005 | CN1597698A Cation antibacterial peptide |
| 03/23/2005 | CN1597697A Human parathyrin 1.34 peptide related peptide-Pro-Pro-[Arg11 hPTH (1.34)-Pro-Pro |
| 03/23/2005 | CN1597696A Biological Function of new DRAB type zinc finger protein 2HP 333 |
| 03/23/2005 | CN1597695A Active GSLL-39 fragment of gene recombination human antibacterial peptide mh CAP-18 and its preparation method and use |
| 03/23/2005 | CN1597694A Meningococcal antigens |
| 03/23/2005 | CN1597691A Method of improving king crab element gene with higher antibacterial activity and high effect expression |
| 03/23/2005 | CN1596983A Composition of nanometer SOD and ginseng or its extract and its preparation method |
| 03/23/2005 | CN1596982A Composition of nanometer SOD and astragalus root or its extract and its preparation method |
| 03/23/2005 | CN1596981A Composition of nanometer SOD and pueraria root or its extract and its preparation method |
| 03/23/2005 | CN1596976A Polypeptide vaccine capable of effectively preventing pointed condyloma |
| 03/23/2005 | CN1596975A Composition of nanometer SOD and animal medicine or its extract and its preparation method |
| 03/23/2005 | CN1596974A Haemopoietin nasal administration medicnment and its preparation method and use |
| 03/23/2005 | CN1596973A Interferon-ginseng diol saponin slow-releasing tablet |
| 03/23/2005 | CN1596972A Slow-releasing oxytocic for artificial inducting maturation and ovulation and ejaculation rockfish and use |
| 03/23/2005 | CN1194092C Medusa cystatin Protease inhibitor gene, and expression and use therof |
| 03/23/2005 | CN1194090C Growth factor and genetic sequence for encoding same |
| 03/23/2005 | CN1194087C Earthworm fine lyase 2 and its coding sequence and use |
| 03/23/2005 | CN1194016C New human chorionic gonadotropin-lutropin fusion protein and its prepn and use |
| 03/23/2005 | CN1194015C Effective renaturation liquid of recombinant human interon inclusion boby and renaturation method |
| 03/23/2005 | CN1194014C Coupled cmpound of hematopoietin and polyethylene glycol |
| 03/23/2005 | CN1194011C Preparation method and use of cobra Short-chain nervous cobratoxin |
| 03/23/2005 | CN1194010C Human protein with the function of inhibiting cancer cell growth and its coding sequence |
| 03/23/2005 | CN1194007C Separation, synthesis and application in medicine for P6A'S metabolic product |
| 03/23/2005 | CN1194006C Peptide derivatives and their pharmaceutically acceptable salts, processes for preparation of both, and use thereof |
| 03/23/2005 | CN1193790C Thymosin composition injection and its prepn method |
| 03/23/2005 | CN1193789C Application of thyroxine for treating tumor |
| 03/23/2005 | CN1193788C Beta 2-adrenergic receptor agonist |
| 03/23/2005 | CN1193756C SGK2 and SGK3 used as diagnostic and therapeutic targets |
| 03/23/2005 | CN1193745C Salmon calcitonin snuff inhalant and its prepn method |
| 03/23/2005 | CN1193742C Method of producing morphologically uniform microcapsules |
| 03/22/2005 | US6870046 Antisense modulation of interferon gamma receptor 2 expression |
| 03/22/2005 | US6870042 Mutants of streptococcal toxin A and methods of use |
| 03/22/2005 | US6870033 Antibody fragment-polymer conjugates and humanized anti-IL-8 monoclonal antibodies |
| 03/22/2005 | US6870031 Haemopoietin receptor and genetic sequences encoding same |
| 03/22/2005 | US6870030 Nucleotide sequences coding polypeptide for use in the treatment and diagnosis of nervous system and tumor disorders |
| 03/22/2005 | US6870029 Method of diagnosing and treating gliomas |
| 03/22/2005 | US6870028 Biologically active peptides and compositions, their use |
| 03/22/2005 | US6869976 Dispersion or complexes of calcium sulfate in polymers such as polyethylene glycol or dextran sulfate; is a solid matrix due to hydration; especially containing an antibiotic for treating bone disorders |
| 03/22/2005 | US6869974 Pharmaceutical compounds |
| 03/22/2005 | US6869964 Inhibiting NS3 (non-structural proteins) proteases; tripeptides |
| 03/22/2005 | US6869936 Drug delivery via adenovirus capsids; for treatment of rheumatoid arthritis |
| 03/22/2005 | US6869935 Gene Therapy for proliferative vitreoretinopathy |
| 03/22/2005 | US6869933 Peptides having an amino acid sequences of the partial region of the protein from human immunodeficiency virus; cytotoxic t-cells (ctl) |
| 03/22/2005 | US6869932 Immobilizated growth hormone releasing factor |
| 03/22/2005 | US6869931 Inhibition of cytokines |
| 03/22/2005 | US6869930 Protracted profile; injectable |
| 03/22/2005 | US6869929 Autoimmune disease; cardiovascular disorders; rheumatic disorders |
| 03/22/2005 | US6869928 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins and uses thereof |
| 03/22/2005 | US6869927 Keratinocyte growth factor-2 formulations |
| 03/22/2005 | US6869926 Comprises amylin/adrenomedullin which stimulates chondrocyte proliferation; for treatment of cartilage disorders/bone growth disorders |
| 03/22/2005 | US6869925 Comprises serine leukocyte protease inhibitor for treatment of HIV |
| 03/22/2005 | US6869924 Human derived monocyte attracting purified protein product useful in a method of treating infection and neoplasms in a human body, and the cloning of full length cDNA thereof |
| 03/22/2005 | US6869795 Antisense compositions and cancer-treatment methods |
| 03/22/2005 | US6869790 Preparation of DNA encoding factor XIIIA |
| 03/22/2005 | US6869789 Heparinase III and uses thereof |
| 03/22/2005 | US6869778 Tissue type plasminogen activator (t-PA) variants: compositions and methods of use |
| 03/22/2005 | US6869760 Use of prostate tumor inducing gene for detection of cancer cells |
| 03/22/2005 | US6869610 Pain treatment by peripheral administration of a neurotoxin |
| 03/22/2005 | US6869609 By continuous intravenous administration to suppress blood urea nitrogen (BUN) and creatinine levels; repair factor in renal injuries |
| 03/22/2005 | US6869605 Anticarcinogenic agents |
| 03/22/2005 | US6869604 Ribonuclease with anti-tumor activity that retains its activity when produced as a single chain fusion protein |
| 03/22/2005 | US6869603 A kit containing the enzyme lipoprotein lipase in a stabilized form in a container and a topical formulation of monoglycerides, diglycerides or triglycerides of synthetic, plant or animal origin for application to human skin |
| 03/22/2005 | US6869600 Combined treatment of multiple sclerosis |
| 03/22/2005 | CA2379672C Biodegradable poly(alkylene oxide)-poly(p-dioxanone) block copolymer soluble in organic solvents, and drug delivery composition comprising same |
| 03/22/2005 | CA2142638C Antibiotic wap-8294a, method for preparing the same and antibacterial composition |
| 03/22/2005 | CA2103059C Method for making humanized antibodies |
| 03/19/2005 | CA2441724A1 Treatment of regulation of atopic dermatitis |
| 03/17/2005 | WO2005024059A2 Methods for identifying compounds for inhibiting fever |
| 03/17/2005 | WO2005024058A2 Compounds for the treatment of diseases involving cognitive impairment, such as alzheimer’s disease, and methods for identifying such compounds |
| 03/17/2005 | WO2005024057A1 Method of identifying a compound that changes the amyloid-beta precursor protein processing in a cell |
| 03/17/2005 | WO2005024044A2 Method for the production of fusion proteins in transgenic mammal milk |
| 03/17/2005 | WO2005024040A2 TARGET AND METHOD FOR INHIBITION OF BACTERIAL RNA POLYMERASE: MINIMIZED DERIVATIVES OF PEPTIDE ANTIBIOTIC MccJ25 |
| 03/17/2005 | WO2005024035A1 Coiled-coil fusion proteins comprising cell receptor domains |
| 03/17/2005 | WO2005024022A1 Tick engorgement factor proteins |
| 03/17/2005 | WO2005023996A2 METHODS OF INDUCING THE EXPRESSION OF BONE MORPHOGENETIC PROTEINS (BMPs) AND TRANSFORMING GROWTH FACTOR-β PROTEINS (TGF-βs) IN CELLS |
| 03/17/2005 | WO2005023980A2 Use of complement protein c3 and its derivatives in enhancing mammalian embryo development |
| 03/17/2005 | WO2005023868A1 Serine protease and polynucleotides which encode the serine protease |
| 03/17/2005 | WO2005023866A2 Peptides that inhibit complement activation |
| 03/17/2005 | WO2005023862A2 Homogeneous preparations of il-28 and il-29 |
| 03/17/2005 | WO2005023861A2 Gdnf-related neuropeptides |
| 03/17/2005 | WO2005023860A2 Modified il-4 mutein receptor antagonists |
| 03/17/2005 | WO2005023859A1 A protein involved in carcinoma |
| 03/17/2005 | WO2005023857A2 Agent derived from tortoise spleen stimulating mammalian hemopoiesis |
| 03/17/2005 | WO2005023852A2 Epilancin 15x lantibiotic |
| 03/17/2005 | WO2005023851A1 Plasminogen/plasmin binding polypeptides and nucleic acids therefore |
| 03/17/2005 | WO2005023846A1 New antitumoral compounds |
| 03/17/2005 | WO2005023845A2 Cyclic peptides acting as urotensin-ii antagonists |
| 03/17/2005 | WO2005023837A2 Ebola peptides and immunogenic compositions containing same |
| 03/17/2005 | WO2005023834A2 Peptides and compounds that bind to thrombopoietin receptors |
| 03/17/2005 | WO2005023826A2 Polymorphic nucleoside compounds |
| 03/17/2005 | WO2005023804A1 Peptidyl heterocyclic ketone derivatives and preparation processes |
| 03/17/2005 | WO2005023755A1 Novel method for synthesizing esters of n-[(s)-1-carboxybutyl]-(s)-alanine and use thereof for synthesizing perindopril |
| 03/17/2005 | WO2005023328A2 Methods for intradermal delivery of therapeutics agents |